Revive Therapeutics Positive Results in Bucillamine Research for Nerve-Agent Exposure
Revive Therapeutics Ltd. reports significant findings from a study on bucillamine's effectiveness against nerve-agent exposure, showing no associated pulmonary hemorrhage compared to N-acetylcysteine.